News & Events

In response to the nationwide shortage of ranitidine and other H2 antagonists, BOPA have produced a guideline on the use of H2 antagonists for the prevention and management of hypersensitivity…

The consent form project team is very pleased to announce that the national breast consent forms are now available on the CRUK website at : www.cruk.org/sact_consent. In collaboration with Anne…

The May 2020 Newsletter from the BOPA committee has been sent to subscribers. If you did not receive this then please update your preference on ‘Your Dashboard’ once you have…

To submit your abstract and get further information on this click here If you are planning to submit an abstract to communicate evaluations of services or research relating to Covid-19…

Cancer Research UK’s patient information services can help people affected by cancer, despite the coronavirus crisis. All the information on CRUK’s ‘About cancer’ website comes direct from the experts –…

The Centre for Medicines Optimisation, Research and Education was initiated at UCL/UCLH to provide an infrastructure to help practising pharmacists conduct more research. Within Cancer this has benefited researchers from…

Please see the BOPA 2019 Winter Survey Results HERE

Please see minutes for the February BOPA Executive TCON HERE

Please see minutes for the January BOPA Executive TCON HERE

  In response to the COVID-19 pandemic the guidance with three potential scenarios for remote consent is now available. On behalf of the  SACT consent form national steering group, the…

Message from Steve Williamson, NHS England Lead Cancer Pharmacist 29th April 2020 – NHSE Interim treatment options   Dear Colleague You may have seen that NICE has published an updated…

BOPA is please to inform our membership that the ISOPP 2019 conference generated a surplus. In line with HMRC guidance this surplus will be classed as restricted funds and will…